Symbol="VIR"
AssetType="Common Stock"
Name="Vir Biotechnology Inc"
Description="Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California."
CIK="1706431"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1750633000"
EBITDA="-255975008"
PERatio="None"
PEGRatio="None"
BookValue="13.49"
DividendPerShare="0"
DividendYield="0"
EPS="-2"
RevenuePerShareTTM="3.68"
ProfitMargin="-0.534"
OperatingMarginTTM="-0.55"
ReturnOnAssetsTTM="-0.0694"
ReturnOnEquityTTM="-0.139"
RevenueTTM="490721000"
GrossProfitTTM="1032030000"
DilutedEPSTTM="-2"
QuarterlyEarningsGrowthYOY="0.585"
QuarterlyRevenueGrowthYOY="-0.949"
AnalystTargetPrice="33.88"
TrailingPE="-"
ForwardPE="4.361"
PriceToSalesRatioTTM="1.409"
PriceToBookRatio="1.604"
EVToRevenue="0.52"
EVToEBITDA="0.789"
Beta="0.127"
num_52WeekHigh="31.55"
num_52WeekLow="12.14"
num_50DayMovingAverage="17.82"
num_200DayMovingAverage="23.68"
SharesOutstanding="134251000"
DividendDate="None"
ExDividendDate="None"
symbol="VIR"
open="13.04"
high="13.07"
low="12.87"
price="12.90"
volume="779397.00"
latest_trading_day="2023-08-30"
previous_close="13.04"
change="-0.14"
change_percent="-1.0736%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="70"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="1076525"
Change_recent_avg="0.02"
Delta_recent_avg="0.71"
Variance_recent_avg="0.36"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1163"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0197.jpeg"
image_negative_thumbnail_id_2="158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="687"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0021.jpeg"
image_positive_thumbnail_id_2="976"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
